Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy:

Coralie Jacquet1, Arnaud Garnier2, Emmanuel Cheuret1

  • 1Service de Neurologie Pédiatrique, Hôpital des Enfants, TSA, Toulouse, France.

Neuropediatrics
|March 2, 2016
PubMed

Insights

Steroids are standard for pediatric optic neuritis, but some children resist treatment. Plasma exchange and immunoadsorption offer effective alternatives for steroid-resistant cases in children.

Area of Science:

  • Pediatric Neurology
  • Ophthalmology
  • Immunology

Background:

  • Steroids are the primary treatment for pediatric optic neuritis (ON).
  • Current steroid treatment protocols for pediatric ON are not standardized.
  • Some children exhibit resistance to conventional steroid therapy.

Observation:

  • This study reports on four pediatric patients with optic neuritis (ON) who did not respond to steroid treatment.
  • Two patients were treated with plasma exchange (PE).
  • Two patients were treated with immunoadsorption (IA).

Findings:

  • Both plasma exchange (PE) and immunoadsorption (IA) were utilized as alternative therapies for steroid-resistant pediatric optic neuritis (ON).
  • Treatment protocols and observed side effects for PE and IA in these pediatric cases are described.
  • These findings suggest PE and IA as viable options for managing refractory ON in children.

Implications:

  • Plasma exchange (PE) and immunoadsorption (IA) show promise as effective treatments for pediatric optic neuritis (ON) when steroids fail.
  • Further research is warranted to establish standardized protocols for PE and IA in pediatric ON management.
  • These alternative therapies could improve outcomes for children with difficult-to-treat optic neuritis.